Janux Therapeutics, Inc. Increase (Decrease) in Other Noncurrent Assets
Janux Therapeutics, Inc. (JANX) reported Increase (Decrease) in Other Noncurrent Assets of $305.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-06
- Janux Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$1.03M.
- Janux Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was $1.34M.
- Janux Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$19.00K, a 131.15% decline year-over-year.
- Janux Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$66.00K, a 136.07% decline year-over-year.
- Janux Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2025 was -$276.00K, a 173.60% decline from fiscal 2024.
- Janux Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2024 was $375.00K, a 66.49% decline from fiscal 2023.
- Janux Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2023 was $1.12M, a 11.89% decline from fiscal 2022.
- Janux Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2022 was $1.27M, a 223.98% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $305.00K 10-Q · filed 2026-08-06 | $286.00K derived: sum of 3 quarters · filed 2026-08-06 | $220.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.34M 10-Q · filed 2026-05-07 | $1.32M derived: sum of 2 quarters · filed 2026-05-07 | $1.25M derived: sum of 3 quarters · filed 2026-05-07 | $1.15M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$85.00K derived: sum of 2 quarters · filed 2026-02-26 | -$184.00K derived: sum of 3 quarters · filed 2026-08-06 | -$276.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | -$66.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$165.00K derived: sum of 2 quarters · filed 2026-08-06 | -$257.00K 10-Q · filed 2025-11-06 | -$196.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$99.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$191.00K 10-Q · filed 2026-08-06 | -$130.00K derived: sum of 3 quarters · filed 2026-08-06 | $53.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$92.00K 10-Q · filed 2026-05-07 | -$31.00K derived: sum of 2 quarters · filed 2026-05-07 | $152.00K derived: sum of 3 quarters · filed 2026-05-07 | $268.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $244.00K derived: sum of 2 quarters · filed 2026-02-26 | $360.00K derived: sum of 3 quarters · filed 2026-02-26 | $375.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $183.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $299.00K derived: sum of 2 quarters · filed 2025-11-06 | $314.00K 10-Q · filed 2025-11-06 | $509.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $116.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $131.00K 10-Q · filed 2025-08-07 | $326.00K derived: sum of 3 quarters · filed 2026-02-26 | $207.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $15.00K 10-Q · filed 2025-05-08 | $210.00K derived: sum of 2 quarters · filed 2026-02-26 | $91.00K derived: sum of 3 quarters · filed 2026-02-26 | $913.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $195.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $76.00K derived: sum of 2 quarters · filed 2026-02-26 | $898.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.12M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$119.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $703.00K derived: sum of 2 quarters · filed 2024-11-06 | $924.00K 10-Q · filed 2024-11-06 | $1.24M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $822.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $1.04M 10-Q · filed 2024-08-07 | $1.36M derived: sum of 3 quarters · filed 2025-02-27 | $2.50M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $221.00K 10-Q · filed 2024-05-08 | $534.00K derived: sum of 2 quarters · filed 2025-02-27 | $1.68M derived: sum of 3 quarters · filed 2025-02-27 | $1.55M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $313.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.46M derived: sum of 2 quarters · filed 2025-02-27 | $1.32M derived: sum of 3 quarters · filed 2025-02-27 | $1.27M 10-K · filed 2025-02-27 |
| 2022-09-30 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.01M derived: sum of 2 quarters · filed 2023-11-07 | $957.00K 10-Q · filed 2023-11-07 | $1.21M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$130.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$185.00K 10-Q · filed 2023-08-08 | $67.00K derived: sum of 3 quarters · filed 2023-08-08 | $207.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$55.00K 10-Q · filed 2023-05-09 | $197.00K derived: sum of 2 quarters · filed 2023-05-09 | $337.00K derived: sum of 3 quarters · filed 2023-05-09 | $337.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $252.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $392.00K derived: sum of 2 quarters · filed 2023-03-10 | $392.00K derived: sum of 3 quarters · filed 2023-03-10 | $392.00K 10-K · filed 2023-03-10 |
| 2021-09-30 | $140.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $140.00K derived: sum of 2 quarters · filed 2022-11-10 | $140.00K 10-Q · filed 2022-11-10 | $140.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $0.00 derived: sum of 3 quarters · filed 2022-08-09 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | $0.00 derived: sum of 2 quarters · filed 2022-05-10 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $0.00 10-K · filed 2022-03-18 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |